It is a link for moving within the page.

Go to the main.
Go to the global navigation.
Go to navigation by category.
Go to the footer.

News Releases

2021

August

2 AUG 2021Nutraceuticals: Production and Sales of Fibe-Mini Begin in Indonesia

July

26 JUL 2021Nutraceuticals: Reflecting Customer Concerns Introduction of ORONAMIN C DRINK in Label-free Bottles

21 JUL 2021Nutraceuticals: U.S. Supplement Brand Nature Made Marks 50th Anniversary/Named #1 Pharmacist Recommended Vitamin and Supplement for 24 Years

21 JUL 2021Nutraceuticals: Otsuka Pharmaceutical Responds to New Lifestyles with Measures for Prevention of Heat Disorders at Inter-High 2021 Supporting safe operation and health of competitors and officials for summer Inter-High School Championships

9 JUL 2021Nutraceuticals: Pharmavite, a U.S. subsidiary of Otsuka Pharmaceutical, acquires Uqora, a provider of women's urinary tract health products

8 JUL 2021Pharmaceuticals: Otsuka Files Application in Japan for Approval of Auto-Injector Dosage Form for AJOVY^® Subcutaneous Injection 225 mg for Preventive Treatment of Migraine

2 JUL 2021Pharmaceuticals: Otsuka Pharmaceutical and Shanghai Rightongene AnnounceCollaboration to Commercialize WT1 mRNA Assay Kit in China

June

30 JUN 2021Pharmaceuticals: Otsuka Obtains New, High-Sensitivity Biomarker Measurement Technology- Technology using surface plasmon field-enhanced fluorescence spectroscopy -

25 JUN 2021Pharmaceuticals: Otsuka Has Filed a Marketing Authorization Application to the European Medicines Agency for Voclosporin for the Treatment of Patients with Lupus Nephritis

24 JUN 2021Pharmaceuticals: AJOVY^® Subcutaneous Injection 225 mg Syringe, as a Preventive Treatment of Migraine, Granted Approval in Japan

18 JUN 2021Pharmaceuticals: Approval in Japan for Otsuka's minor BCR-ABL mRNA measurement kit A marker to monitor treatment effectiveness for acute lymphoblastic leukemia (ALL)

16 JUN 2021Pharmaceuticals: Quick Navi^TM - Flu+COVID-19 Ag Receives Regulatory Approval in Japan as a Combo, Rapid Diagnostic Kit for Influenza and COVID-19- Simultaneous testing for both viruses using a single test sample -

9 JUN 2021Corporate: Otsuka Group Complete Introduction of CO₂-free Electricity for All 23 Manufacturing Facilities in Japan -Contributing to a more than 40% reduction in annual CO₂ emissions in Japan-

1 JUN 2021Pharmaceuticals: Otsuka and Akebia Announce U.S. FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease

April

27 APR 2021Corporate: Otsuka Group Company, A&P Inphatec, Commences Sales in U.S. of XylPhi-PD™,a Bactericidal Treatment for Pierce's Disease in Grapevines

15 APR 2021Corporate: Otsuka Pharmaceutical Receives First Certification as Tokyo Metropolitan Government Sports Promotion Model Company (Practical Division) Recognized for providing opportunities for exercise adapted for new lifestyles

13 APR 2021Pharmaceuticals: Otsuka and Lundbeck announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia

March

30 MAR 2021Pharmaceuticals: Otsuka and Akebia Announce Submission of New Drug Application to the FDA for Approval of Akebia's Vadadustat

24 MAR 2021Pharmaceuticals: Otsuka to Launch QuickNavi^TM-H.pylori, a Helicobacter pylori Quick Detection Kit- Test results in eight minutes and stool collection tools provided in one pack -

22 MAR 2021Pharmaceuticals: Otsuka Has Filed an Application in Japan for Regulatory Approval of OPC-61815, a V₂ -Receptor Antagonist for the Treatment of Cardiac Edema

22 MAR 2021Pharmaceuticals: New Drug Application for Oral Disintegrated Tablet Formulation of TAKECAB_® for Treatment of Acid-Related Disease

16 MAR 2021Pharmaceuticals: Otsuka and Perception Neuroscience Announce Collaboration on Development of PCN-101 (R-ketamine) in Japan for Treatment of Depressive Disorders

10 MAR 2021Corporate: Otsuka Pharmaceutical Appointments of Board Members and Statutory Auditors (PDF:57.4 KB)

2 MAR 2021Nutraceuticals: A Delicious Snack That's Good for You Announcing SOYJOY Coffee & Nuts Soy protein from low-GI whole soy

February

26 FEB 2021Nutraceuticals: Convenient Sizes of UL·OS Medicated Scalp Shampoo and Medicated Skin Wash Launched to Promote Trial Use

25 FEB 2021Corporate: Otsuka to Construct a Drug Discovery Center in Osaka Prefecture, Japan

9 FEB 2021Corporate: Office Divisions of Five Otsuka Group Companies to Switch to Green Power

3 FEB 2021Pharmaceuticals: Otsuka and Illumina Announce Agreement on Development and Commercialization of IVD Test Kit for Patients in Japan with Blood Cancer

1 FEB 2021Corporate: Otsuka Pharmaceutical Certified as Sports Yell Company for 4th Consecutive Year -Providing Opportunities for Exercise Tailored for New Lifestyles-

January

29 JAN 2021Corporate: Otsuka Pharmaceutical to Transfer All Shares of Bean Stalk Snow to Megmilk Snow Brand

18 JAN 2021Nutraceuticals: Introduction of POCARI SWEAT Label-free Bottles
Revamped packaging to contribute to a sustainable society

2020

December

17 DEC 2020Pharmaceuticals: Formation of a Licensing Agreement Covering Japan and Europe for the Lupus Nephritis Drug "Voclosporin"

10 DEC 2020Nutraceuticals: Otsuka Pharmaceutical Signs On as "B. League Supporting Company"
-To cooperate with physical conditioning and regional healthcare-related initiatives-

November

16 NOV 2020Nutraceuticals: UL·OS Medicated Scalp Shampoo and Medicated Skin Wash to Appear in New Packaging

October

30 OCT 2020Pharmaceuticals: Quick Navi^TM Rapid Diagnostic Test in Japan Now Supports Simultaneous Testing for Influenza and COVID-19 Through Collection of a Single Testing Sample

15 OCT 2020Nutraceuticals: Debut of InnerSignal Skin Care Brand Outside Japan - Launched in South Korea as Functional Cosmetics with Two Key Benefits -

15 OCT 2020Pharmaceuticals: Otsuka and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitabine in patients with previously treated AML and MDS/CMML

12 OCT 2020Pharmaceuticals: Positive Top-Line Results in Phase 3 Trial of OPC-61815, a V₂ -Receptor Antagonist for the Treatment of Cardiac Edema

5 OCT 2020Pharmaceuticals: Quick Navi^TM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front of Nasal Cavity

September

30 SEP 2020Corporate: Otsuka Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-

28 SEP 2020Pharmaceuticals: Otsuka Has Filed an Application in Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug

25 SEP 2020Pharmaceuticals: Otsuka's ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan

18 SEP 2020Nutraceuticals: - Creating a Society that Supports Ongoing Employee Health - Full-scale launch of "Kenko Shacho" community website connecting corporate leaders

10 SEP 2020Nutraceuticals: Smart Nutrition for New Lifestyles Announcing SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astringency and Savor of Green Tea

7 SEP 2020Nutraceuticals: Otsuka Pharmaceutical Supports High School Students in Summer 2020
Supporting events across Japan that are close to their hearts, including alternative athletic competitions

3 SEP 2020Pharmaceuticals: Top-line Results from Global Phase 3 Program of Vadadustat, a Drug Candidate for Treatment of Renal Anemia due to Chronic Kidney Disease in Non-Dialysis Patients

August

26 AUG 2020Pharmaceuticals: Novartis Pharma and Otsuka to Launch Entresto^® Tablets in Japan for Patients with Chronic Heart Failure

11 AUG 2020Pharmaceuticals: Otsuka to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag-Confirmation of test results in just 15 minutes, and easy-to-read results shown in two contrasting colors-

July

29 JUL 2020Pharmaceuticals: Otsuka Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine

8 JUL 2020Pharmaceuticals: Otsuka announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI^®, an oral hypomethylating agent (HMA) therapy for MDS and CMML

June

29 JUN 2020Pharmaceuticals: Novartis Pharma obtains manufacturing and marketing approval in Japan for Entresto^® tablet as angiotensin receptor neprilysin inhibitor (ARNI) for chronic heart failure

29 JUN 2020Pharmaceuticals: Samsca^®approved in Japan for additional indication of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH)

29 JUN 2020Pharmaceuticals: Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications

24 JUN 2020Pharmaceuticals: Clinical program for NY-ESO-1/siTCR^TM gene therapy candidate receives designation in Japan as Orphan Regenerative Medicine

19 JUN 2020Pharmaceuticals: Japan's MHLW grants Sakigake Designation to comprehensive genomic profiling assay for hematologic malignancies co-developed by Otsuka

16 JUN 2020Nutraceuticals: Introduction of Set of Heat Disorder-related Teaching Materials: "Get Back That Sweat! Preventing Heat Disorders Together"

16 JUN 2020Pharmaceuticals: Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, AILAMIDE^® Combination Ophthalmic Suspension

12 JUN 2020Pharmaceuticals: Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients

May

25 MAY 2020Pharmaceuticals: Deltyba^® (delamanid) approved in Russian Federation for treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)

22 MAY 2020Pharmaceuticals: Launch of Aspirin/Vonoprazan Fumarate Combination Tablets: "Cabpirin_® Combination Tablets"

5 MAY 2020Pharmaceuticals: Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis

April

27 APR 2020Corporate: Otsuka Pharmaceutical to use CO2-free electricity at all plants in Japan (PDF:96.4 KB)

24 APR 2020Nutraceuticals: Research on the Relationship Between Hair Problems and Capacity to Produce Equol

20 APR 2020Pharmaceuticals: Otsuka Enters into Licensing Agreement in Japan for Bempedoic Acid, a Treatment for Hypercholesterolemia

1 APR 2020Pharmaceuticals: Otsuka to Introduce QuickNavi^TM-Adeno2, an Adenovirus Quick Measurement Kit- Faster and clearer test results with two contrasting colors -

March

26 MAR 2020Pharmaceuticals: Development of the first comprehensive genomic profiling assay for hematologic malignancies in Japan- Consortium of major Japanese hospitals and Otsuka Pharmaceutical start a project to evaluate its clinical utility -

26 MAR 2020Pharmaceuticals: Otsuka Announces Top-line Results from Two Phase 3 Studies in Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)

25 MAR 2020Pharmaceuticals: Otsuka's Busulfex Receives Additional Indication in Japan as a Conditioning regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma

25 MAR 2020Pharmaceuticals: Cabpirin_® Combination Tablet Receives Regulatory Approval in Japan for Treatment of Acid-related Diseases in Patients Needing Low-dose Aspirin

16 MAR 2020Nutraceuticals: Dietary Education App "SketchCook"
Recognized with Ministry of Education, Culture, Sports, Science and Technology（MEXT）
"Award for Companies Promoting Experience-based Learning Activities for Youth 2019"

13 MAR 2020Nutraceuticals: Newly published findings on inhibitory effect of near-infrared (IRA) radiation on human epidermal cell proliferation and potential mechanisms

10 MAR 2020Corporate: Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF:57.4 KB)

3 MAR 2020Nutraceuticals: Introducing InnerSignal Rejuvenate ONE－All-in-One Skin Care Product with Time-Lapse Penetration Combines Lightening and Three Basic Skin Care Functions－

2 MAR 2020Pharmaceuticals: Otsuka enters into co-promotion agreement for angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 in Japan

February

27 FEB 2020Pharmaceuticals: First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis

27 FEB 2020Pharmaceuticals: Otsuka Pharmaceutical Establishes Subsidiary in Malaysia

27 FEB 2020Nutraceuticals: Introducing New UL·OS Face & Body Sheet A single sheet provides convenient facial and body care

26 FEB 2020Nutraceuticals: Launch of "Health Support Plus"
Service to manage workforce health based on desknet's NEO groupware

25 FEB 2020Nutraceuticals: Whole soy nutrition bar delivers the same satisfying crunchy texture with a significant reduction in sugars
SOYJOY Peanuts Renewal Launch

14 FEB 2020Pharmaceuticals: Otsuka Pharmaceutical and the Japan Kidney Association Form Collaborative Agreement -Aim to identify practical uses of basic research in the kidney field-

12 FEB 2020Pharmaceuticals: Otsuka announces that subsidiary Astex Pharmaceuticals' NDA for ASTX727 (oral C-DEC), for the treatment of MDS and CMML, has been accepted for priority review by the U.S. FDA

6 FEB 2020Nutraceuticals: Tokyo Marathon 2020 - Connecting With the World Otsuka Pharmaceutical to be an Official Partner for 14th consecutive year

January

31 JAN 2020Nutraceuticals: Otsuka Pharmaceutical Establishes Health Beverage Subsidiary in Mexico

27 JAN 2020Pharmaceuticals: Otsuka announces positive top-line results from clinical trials in Japan offremanezumab as a prophylactic treatment for migraine

24 JAN 2020Corporate: Otsuka Pharmaceutical Awarded Grand Prize in Tokyo Metropolitan Government Women's Participation Awards for First Year of the Reiwa Era

21 JAN 2020Pharmaceuticals: Otsuka enters multi-project drug discovery collaboration with PhoreMost Limited

2019

December

11 DEC 2019Corporate: Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd. (PDF:65.0 KB)

9 DEC 2019Pharmaceuticals: Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA^® Combination Ophthalmic Solution

November

28 NOV 2019Pharmaceuticals: POConePlus_® Infrared Spectrophotometer for Diagnosis of H. pylori infection launched in Japan

27 NOV 2019Corporate: Construction Completed on Otsuka's New Pharmaceutical Factory Plant in Mima City, Tokushima Prefecture, Japan

27 NOV 2019Pharmaceuticals: Otsuka Launches New SAMSCA Formulation in Japan: SAMSCA^® OD Tablets

18 NOV 2019Corporate: Otsuka Pharmaceutical Cosponsors "Asan Walking Festa in Itano" as Part of Community Health Promotion Efforts

12 NOV 2019Pharmaceuticals: Otsuka Pharmaceutical and Avanir Pharmaceuticals to Continue Clinical Development ofInvestigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer's Dementia

October

16 OCT 2019Pharmaceuticals: RS Virus Rapid-measurement Kit Quick Navi^TM-RSV2 To Be Launched in Japan- Faster test results and enhanced visual features with two color lines -

15 OCT 2019Nutraceuticals: Presentation of Effects of lactic acid bacterium B240 at Palynological Society of Japan

1 OCT 2019Nutraceuticals: Three New Flavors of Easy-to-Drink Balanced Nutrition Beverage
Introducing Calorie Mate Liquid

September

27 SEP 2019Pharmaceuticals: Otsuka's Subsidiary Avanir Pharmaceuticals Reports Top-line Data from Second Phase 3 Trial Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia

26 SEP 2019Pharmaceuticals: Otsuka Applies for the Additional Indication in Japan of Bipolar Disorder for ABILIFY MAINTENA for Suspended Release Injectable Suspension

26 SEP 2019Nutraceuticals: New Series Expands the SOYJOY Line of Whole Soy Nutrition Bars SOYJOY Scone Bar Plain

20 SEP 2019Corporate: Otsuka Pharmaceutical Greenhouse Gas Emissions Reduction Targets Earn Science Based Targets (SBT) Initiative Certification

13 SEP 2019Nutraceuticals: Otsuka Pharmaceutical Enters into Cooperative Agreement with Niigata Prefecture to Support Prefectural Residents' Health Promotion Project

August

28 AUG 2019Pharmaceuticals: Approval for the Additional Formulation of Samsca^® OD Tablets in Japan

23 AUG 2019Nutraceuticals: UL·OS Men's Skincare BrandRenewal Launch of Three Moisturizing Products

22 AUG 2019Corporate: Otsuka Group Adopts CO₂-free Electricity Annual CO₂ Emissions to Decline by Approximately 9%

19 AUG 2019Corporate: Otsuka Pharmaceutical Participates in Summer Events in Tokushima, Japan Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink PRESENTS Awa Odori Sound Festival

July

22 JUL 2019Nutraceuticals: Otsuka Pharmaceutical Enters into Comprehensive Cooperative Agreement with Nagano Prefecture

June

28 JUN 2019Nutraceuticals: POCARI SWEAT Marketing Wins Top Prize at Japan Marketing Awards

28 JUN 2019Nutraceuticals: Deliciously Illustrated SketchCook
Wins in Three Categories at PR Awards Asia 2019 ― Dietary education app promotes awareness about the importance of meals and nutrition to children―

7 JUN 2019Pharmaceuticals: Otsuka and Taiho Announce that Taiho Will Commercialize Two of Astex Pharmaceuticals' Drug Candidates in North America

7 JUN 2019Pharmaceuticals: Otsuka and its Subsidiary Astex Pharmaceuticals, Inc. Announce Positive Results from a Phase III Clinical Trial of Anticancer Candidate ASTX727

May

22 MAY 2019Pharmaceuticals: Otsuka and Japan Kidney Association
to Collaborative on Autosomal Dominant Polycystic Kidney Disease

April

18 APR 2019Pharmaceuticals: Erdafitinib Receives Regulatory Approval in U.S.

12 APR 2019Nutraceuticals: EQUELLE: Dietary Supplement to Support Women's Health
Expansion of US business through launch of sales via D-to-C channel

8 APR 2019Nutraceuticals: Otsuka Pharmaceutical Establishes Health Beverage Subsidiary in Myanmar

March

28 MAR 2019Nutraceuticals: Otsuka Pharmaceutical to Sponsor 30th Southeast Asian Games 2019 (Philippines)

25 MAR 2019Pharmaceuticals: Otsuka's Subsidiary Avanir Pharmaceuticals Reports Phase 3 Data Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia

11 MAR 2019Pharmaceuticals: Notice regarding the conclusion of co-development/co-promotion activities in Japan for the anti-epileptic drug "E Keppra"

7 MAR 2019Corporate: Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF:56.8 KB)

5 MAR 2019Pharmaceuticals: Selincro Tablets 10mg Launched in Japan

February

27 FEB 2019Nutraceuticals: Refreshing Men's Facial Lotion for Summer ComfortIntroducing UL·OS Medicated Skin Breezy LotionA single product to moisturize, minimize oily shine, and prevent formation of blemishes

19 FEB 2019Nutraceuticals: Otsuka Pharmaceutical to Serve as an Official Partner for Tokyo Marathon 2019
New "Run," "Support," "Boost," Program Benefits All Participants

15 FEB 2019Pharmaceuticals: Otsuka and Lundbeck report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder

14 FEB 2019Pharmaceuticals: Designation Description Change of NY-ESO-1・siTCRTM gene therapy product under "SAKIGAKE Designation System"

13 FEB 2019Pharmaceuticals: Avanir Pharmaceuticals, Inc. Reaches Agreement in Principle with U.S. Department of Justice Regarding NUEDEXTA (dextromethorphan HBr and quinidine sulfate) 20 mg/10 mg capsule

5 FEB 2019Pharmaceuticals: The 1st Japan Open Innovation Prize

4 FEB 2019Nutraceuticals: Introducing SOYJOY Crispy Sakura Special Seasonal Flavor from SOYJOY Brand of Whole Soy Nutrition Bars

January

8 JAN 2019Pharmaceuticals: Selincro (nalmefene) Tablets 10mg Receives Regulatory Approval in Japan

4 JAN 2019Pharmaceuticals: Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder

View More